Stay updated with breaking news from Seanr Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Evaluation of IOS-1002, a LILRB1 (ILT2), LILRB2 (ILT4), KIR3DL1 targeting agent, in combination with KEYTRUDA® (pembrolizumab) as part of ongoing Phase 1a/b trial in advanced solid tumors
- Seasoned immuno-oncology executive brings significant medical and biopharma expertise Schlieren (Zurich Area), Switzerland, and Gaithersburg, MD,...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Centennial Resource Development, Inc. (NASDAQ:NASDAQ:CDEV) Q1 2022 Earnings Conference Call May 5, 2022, 10:00 AM ET Company Participants Sean R.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.